ITCI — Intra-Cellular Therapies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Intra-Cellular Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	224	657	412	592	498
Net Total Accounts Receivable
Net Total Receivables	—	10.8	20.2	75.2	114
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	230	691	467	738	668
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.5	26.3	22.6	16.7	14.6
Other Long Term Assets
Total Assets	251	717	490	755	728
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	36.2	36.9	53.4	83.2	124
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	56.2	60.5	72	98.7	137
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	195	657	418	656	591
Total Liabilities & Shareholders' Equity	251	717	490	755	728
Total Common Shares Outstanding